Differences in Severity of Poison Centers Exposures Involving XTAMPZA ® ER Versus Other Opioid Analgesics
Pain Management · 2023
DOI: 10.2217/pmt-2022-0068 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pain Management, 2023. Verfasst von Stevan Geoffrey Severtson und 3 weiteren Autor:innen. Beteiligte Einrichtung: Rocky Mountain Poison and Drug Safety, Denver Health and Hospital Authority, Denver, CO 80204, USA. Hauptthemen laut MEDLINE: Analgesics, Opioid, Opioid-Related Disorders. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben. Gefördert von: Collegium Pharmaceutical.
Abstract (Originalsprache)
Aims: Xtampza® ER (Collegium Pharmaceutical, MA, USA) is an abuse-deterrent formulation (ADF) of oxycodone intended to deter tampering for use by unintended routes of administration. We assessed whether Xtampza ER exposures were less likely to result in severe medical outcomes relative to other opioid analgesic exposures. Materials & methods: Exposures reported to participating poison centers between 2016 and 2021 inclusive that were followed to a known medical outcome were analyzed. Xtampza ER was compared with other ADF opioids, non-ADF extended-release opioids, single-entity oxycodone immediate-release, unspecified oxycodone and unspecified morphine. Results & conclusion: No Xtampza ER exposures involved unintended routes of administration. Xtampza ER exposures were less likely to be abuse, misuse or suspected suicidal, and medical outcomes were less severe than comparators.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Rocky Mountain Poison and Drug Safety, Denver Health and Hospital Authority, Denver, CO 80204, USA.
Förderung
- Collegium Pharmaceutical
Zitieren
APA
Severtson, S. G., Haanschoten, E. E., Iwanicki, J., & Dart, R. C. (2023). Differences in Severity of Poison Centers Exposures Involving XTAMPZA ® ER Versus Other Opioid Analgesics. Pain Management. https://doi.org/10.2217/pmt-2022-0068
Vancouver
Severtson SG, Haanschoten EE, Iwanicki J, Dart RC. Differences in Severity of Poison Centers Exposures Involving XTAMPZA ® ER Versus Other Opioid Analgesics. Pain Management. 2023. doi:10.2217/pmt-2022-0068
BibTeX
@article{Severtson2023,
author = {Severtson, Stevan Geoffrey and Haanschoten, Emily E and Iwanicki, Janetta and Dart, Richard C},
title = {Differences in Severity of Poison Centers Exposures Involving XTAMPZA ® ER Versus Other Opioid Analgesics},
journal = {Pain Management},
year = {2023},
doi = {10.2217/pmt-2022-0068}
}
EUVIMED